Potential PYC Therapeutics Limited (ASX:PYC) shareholders may wish to note that the CEO & Executive Director, Rohan Hockings, recently bought AU$200k worth of stock, paying AU$1.50 for each share.

Abstract: Python is one of the most popular programming languages among both industry developers and malware authors. Despite demand for Python decompilers, community efforts to maintain automatic ...

On June 11, 2025, the Python core team released Python 3.13.5, the fifth maintenance update to the 3.13 line. This release is not about flashy new language features, instead, it addresses some ...

PYC Therapeutics (ASX: PYC) presented its Q2 2025 investor webinar on May 30, outlining progress across its genetic medicine pipeline while facing continued market skepticism. The company’s stock ...

The last three months have been tough on PYC Therapeutics Limited (ASX:PYC) shareholders, who have seen the share price decline a rather worrying 36%. But that doesn't change the fact that the returns ...

PYC Therapeutics Limited (AU:PYC) has released an update. PYC Therapeutics has dosed its first patient in a clinical trial for its innovative drug candidate, PYC-001, which aims to treat Autosomal ...

Cybersecurity researchers have uncovered a new set of malicious Python packages that target software developers under the guise of coding assessments. "The new samples were tracked to GitHub projects ...

## Summary - The change relates to #6635 is to include compiled python files (.pyc) in the uv run command. - After this change `uv run foo.pyc` should spawn `python foo.pyc`. ## Test Plan - There is a ...

It is no secret that when Solo Select has their name on something, it is going to be exceptional. After all, their motto is "the very best." With industry altering goals and a plan to get there, ...

PYC Therapeutics Limited (AU:PYC) has released an update. PYC Therapeutics Limited has announced a significant breakthrough in treating Phelan-McDermid Syndrome (PMS), a rare neurodevelopmental ...